Common use of Independent Assessor Clause in Contracts

Independent Assessor. The state will identify independent entities with expertise in delivery system improvement to assist with DSRIP administration, oversight and monitoring, including an independent assessor and/or evaluator. An independent assessor will review ACO and CP proposals, progress reports and other related documents, to ensure compliance with approved STCs and Protocols, provided that initial ACO and CP proposals are not subject to review from the independent assessor. The independent assessor shall make recommendations to the state regarding approvals, denials or recommended changes to plans to make them approvable. This entity (or another entity identified by the state) will also assist with the progress reports and any other ongoing reviews of DSRIP project plan; and assist with continuous quality improvement activities. The independent assessor will complete the mid-point assessment, which will individually and systematically assess the performance of demonstration entities (i.e., ACOs, Community Partners, and key Statewide Investment management vendors as determined by the State), including identification of specific challenges and actionable mitigation strategies for mid-course correction for the State’s consideration. The mid-point assessment will cover the time period from July 1, 2017 through December 2019 and the mid-point assessment report will be submitted to CMS by the end of September 2020. Expenditures for the independent assessor are administrative costs the state incurs associated with the management of DSRIP reports and other data. The state must describe the functions of each independent entity and their relationship with the state as part of its Quarterly report requirements. Spending on the independent entities and other administrative cost associated with the DSRIP fund is classified as a state administrative activity of operating the state plan as affected by this demonstration. The state must ensure that all administrative costs for the independent entities are proper and efficient for the administration of the DSRIP Fund. The State may also claim FFP for expenditures related to these administrative activities using DSRIP expenditure authority. DSRIP Advisory Committee. The state will develop and put into action a committee of stakeholders who will be responsible for supporting the clinical performance improvement cycle of DSRIP activities. The Committee will serve as an advisory group offering expertise in health care quality measures, clinical measurement, and clinical data used in performance improvement initiatives, quality, and best practices. Final decision-making authority will be retained by the state and CMS, although all recommendations of the committee will be considered by the State and CMS. Specifically, the Committee will provide feedback to the state regarding: Selection of additional metrics for providers that have reached baseline performance thresholds or exceeded performance targets Assessing the effectiveness of cross-cutting measures to understand how aspects of one system are affecting the other. For example, are BH/SUD/LTSS performance focus areas affecting physical health outcomes? Alignment of measures between systems with purpose, to enable the state to assess the effectiveness in their outcomes across systems Identify actionable new areas of priority, Make systems-based recommendations for initiatives to improve cross-cutting performance.

Independent Assessor. The state will identify independent entities with expertise in delivery system improvement to assist with DSRIP administration, oversight and monitoring, including an independent assessor and/or evaluator. An independent assessor will review ACO and CP proposals, progress reports and other related documents, to ensure compliance with approved STCs and Protocols, provided that initial ACO and CP proposals are not subject to review from the independent assessor. The independent assessor shall make recommendations to the state regarding approvals, denials or recommended changes to plans to make them approvable. This entity (or another entity identified by the state) will also assist with the progress reports and any other ongoing reviews of DSRIP project plan; and assist with continuous quality improvement activities. The independent assessor will complete the mid-point assessment, which will individually and systematically assess the performance of demonstration entities (i.e., ACOs, Community Partners, and key Statewide Investment management vendors as determined by the State), including identification of specific challenges and actionable mitigation strategies for mid-course correction for the State’s consideration. The mid-point assessment will cover the time period from July 1, 2017 through December 2019 and a final version of the mid-point assessment report will be submitted to CMS by the end of September 2020. Expenditures for the independent assessor are administrative costs the state incurs associated with the management of DSRIP reports and other data. The state must describe the functions of each independent entity and their relationship with the state as part of its Quarterly report requirements. Spending on the independent entities and other administrative cost associated with the DSRIP fund is classified as a state administrative activity of operating the state plan as affected by this demonstration. The state must ensure that all administrative costs for the independent entities are proper and efficient for the administration of the DSRIP Fund. The State may also claim FFP for expenditures related to these administrative activities using DSRIP expenditure authority. DSRIP Advisory Committee. The state will develop and put into action a committee of stakeholders who will be responsible for supporting the clinical performance improvement cycle of DSRIP activities. The Committee will serve as an advisory group offering expertise in health care quality measures, clinical measurement, and clinical data used in performance improvement initiatives, quality, and best practices. Final decision-making authority will be retained by the state and CMS, although all recommendations of the committee will be considered by the State and CMS. Specifically, the Committee will provide feedback to the state regarding: Selection of additional metrics for providers that have reached baseline performance thresholds or exceeded performance targets Assessing the effectiveness of cross-cutting measures to understand how aspects of one system are affecting the other. For example, are BH/SUD/LTSS performance focus areas affecting physical health outcomes? Alignment of measures between systems with purpose, to enable the state to assess the effectiveness in their outcomes across systems Identify actionable new areas of priority, Make systems-based recommendations for initiatives to improve cross-cutting performance.

Independent Assessor. The state will identify independent entities with expertise in delivery system improvement to assist with DSRIP administration, oversight and monitoring, including an independent assessor and/or evaluator. An independent assessor will review ACO and CP proposals, progress reports and other related documents, to ensure compliance with approved STCs and Protocols, provided that initial ACO and CP proposals are not subject to review from the independent assessor. The independent assessor shall make recommendations to the state regarding approvals, denials or recommended changes to plans to make them approvable. This entity (or another entity identified by the state) will also assist with the progress reports and any other ongoing reviews of DSRIP project plan; and assist with continuous quality improvement activities. The independent assessor will complete the mid-point assessment, which will individually and systematically assess the performance of demonstration entities (i.e., ACOs, Community Partners, and key Statewide Investment management vendors as determined by the State), including identification of specific challenges and actionable mitigation strategies for mid-course correction for the State’s consideration. The mid-point assessment will cover the time period from July 1, 2017 through December 2019 and the mid-point assessment report will be submitted to CMS by the end of September November 2020. Expenditures for the independent assessor are administrative costs the state incurs associated with the management of DSRIP reports and other data. The state must describe the functions of each independent entity and their relationship with the state as part of its Quarterly report requirements. Spending on the independent entities and other administrative cost associated with the DSRIP fund is classified as a state administrative activity of operating the state plan as affected by this demonstration. The state must ensure that all administrative costs for the independent entities are proper and efficient for the administration of the DSRIP Fund. The State may also claim FFP for expenditures related to these administrative activities using DSRIP expenditure authority. DSRIP Advisory Committee. The state will develop and put into action a committee of stakeholders who will be responsible for supporting the clinical performance improvement cycle of DSRIP activities. The Committee will serve as an advisory group offering expertise in health care quality measures, clinical measurement, and clinical data used in performance improvement initiatives, quality, and best practices. Final decision-making authority will be retained by the state and CMS, although all recommendations of the committee will be considered by the State and CMS. Specifically, the Committee will provide feedback to the state regarding: Selection of additional metrics for providers that have reached baseline performance thresholds or exceeded performance targets Assessing the effectiveness of cross-cutting measures to understand how aspects of one system are affecting the other. For example, are BH/SUD/LTSS performance focus areas affecting physical health outcomes? Alignment of measures between systems with purpose, to enable the state to assess the effectiveness in their outcomes across systems Identify actionable new areas of priority, Make systems-based recommendations for initiatives to improve cross-cutting performance.

Independent Assessor. The state will identify independent entities with expertise in delivery system improvement to assist with DSRIP administration, oversight and monitoring, including an independent assessor and/or evaluator. An independent assessor will review ACO and CP proposals, progress reports and other related documents, to ensure compliance with approved STCs and Protocols, provided that initial ACO and CP proposals are not subject to review from the independent assessor. The independent assessor shall make recommendations to the state regarding approvals, denials or recommended changes to plans to make them approvable. This entity (or another entity identified by the state) will also assist with the progress reports and any other ongoing reviews of DSRIP project plan; and assist with continuous quality improvement activities. The independent assessor will complete the mid-point assessment, which will individually and systematically assess the performance of demonstration entities (i.e., ACOs, Community Partners, and key Statewide Investment management vendors as determined by the State), including identification of specific challenges and actionable mitigation strategies for mid-course correction for the State’s consideration. The mid-point assessment will cover the time period from July 1, 2017 through December 2019 and a final version of the mid-point assessment report will be submitted to CMS by the end of September 2020. Expenditures for the independent assessor are administrative costs the state incurs associated with the management of DSRIP reports and other data. The state must describe the functions of each independent entity and their relationship with the state as part of its Quarterly report requirements. Spending on the independent entities and other administrative cost associated with the DSRIP fund is classified as a state administrative activity of operating the state plan as affected by this demonstration. The state must ensure that all administrative costs for the independent entities are proper and efficient for the administration of the DSRIP Fund. The State may also claim FFP for expenditures related to these administrative activities using DSRIP expenditure authority. DSRIP Advisory Committee. The state will develop and put into action a committee of stakeholders who will be responsible for supporting the clinical performance improvement cycle of DSRIP activities. The Committee will serve as an advisory group offering expertise in health care quality measures, clinical measurement, and clinical data used in performance improvement initiatives, quality, and best practices. Final decision-making authority will be retained by the state and CMS, although all recommendations of the committee will be considered by the State and CMS. Specifically, the Committee will provide feedback to the state regarding: Selection of additional metrics for providers that have reached baseline performance thresholds or exceeded performance targets Assessing the effectiveness of cross-cutting measures to understand how aspects of one system are affecting the other. For example, are BH/SUD/LTSS performance focus areas affecting physical health outcomes? Alignment of measures between systems with purpose, to enable the state to assess the effectiveness in their outcomes across systems Identify actionable new areas of priority, Make systems-based recommendations for initiatives to improve cross-cutting performance.